申请人:CENTROSE, LLC
公开号:US20170049908A1
公开(公告)日:2017-02-23
Extracellular drug conjugates (EDCs) targeting an extracellular protein or portion thereof (e.g., CD38) and comprising a non-cleavable linker including one or two nitrogen heteroatoms are useful in the treatment of diseases such as cancer and immune disorders, including asthma.